Anglo American share price falls again as copper outlook cut keeps pressure on miners

Anglo American share price falls again as copper outlook cut keeps pressure on miners

Anglo American shares fell 1.7% to 3,401 pence in early London trading after the miner cut its 2026 copper output forecast and began a review of De Beers’ carrying value. The company reported a 10% drop in 2025 copper production and flagged $0.2 billion in charges for its Chilean operations. Investors await full-year results on Feb. 20 for updates on costs and asset sales.
Rolls-Royce share price slips in London as buybacks and engine upgrades stay in focus

Rolls-Royce share price slips in London as buybacks and engine upgrades stay in focus

Rolls-Royce shares slipped 0.7% to 1,199.5 pence in early London trading Friday, about 8% below January’s peak. China Airlines signed TotalCare service deals for 36 Trent XWB engines. Rolls-Royce continued its £200 million buyback, repurchasing 458,596 shares on Feb. 5. Investors are watching Boeing’s 787 engine upgrades and share buybacks ahead of earnings.
National Grid share price today: NG edges lower as UK rate-cut bets stay in focus

National Grid share price today: NG edges lower as UK rate-cut bets stay in focus

National Grid shares dipped 0.04% to 1,281.5 pence early Friday, trading near a 52-week high after the Bank of England held rates at 3.75% in a close vote. Utilities saw muted moves as investors weighed rate-cut signals and sector peers’ spending plans. CEO Zoë Yujnovich received a five-year share option, regulatory filings show. National Grid’s full-year results are due May 14.
Compass Group share price slips again as AI fears linger after Q1 update

Compass Group share price slips again as AI fears linger after Q1 update

Compass Group shares fell 1.4% to 2,149 pence in early London trading Friday, extending Thursday’s 8% drop. The company confirmed 7.3% organic revenue growth for the quarter and will switch its LSE trading currency to U.S. dollars from April 1. Investors remain concerned about AI’s impact on office catering demand. Compass maintained its 2026 profit outlook.
Barclays share price rebounds as BoE rate-cut bets swirl; results due Feb 10

Barclays share price rebounds as BoE rate-cut bets swirl; results due Feb 10

Barclays shares rose 0.8% to 470.05 pence in early London trading Friday, rebounding after a 3.5% drop the previous day. The FTSE 100 gained 0.5%. Barclays and NatWest are reportedly preparing rival bids over £2 billion for Evelyn Partners. Investors await Barclays’ full-year results on Feb. 10 amid shifting Bank of England rate expectations.
NatWest stock tries to bounce after BoE spooks UK banks — what to watch before earnings

NatWest stock tries to bounce after BoE spooks UK banks — what to watch before earnings

NatWest shares rose 0.7% to 654.6 pence early Friday, recovering some ground after a 6% drop Thursday triggered by the Bank of England’s split vote on rates. The BoE kept its rate at 3.75% but signaled possible cuts ahead. NatWest repurchased over 800,000 shares this week and will release annual results next Friday.
HSBC stock price steadies after BoE vote jolts UK banks, earnings loom

HSBC stock price steadies after BoE vote jolts UK banks, earnings loom

HSBC shares rose 0.2% to 1,280 pence in early London trading Friday, rebounding after UK banks slid on the Bank of England’s close 5-4 vote to hold rates at 3.75%. HSBC recently increased its stake in International Personal Finance to 9.71%. Investors await HSBC’s annual results on February 25, with focus on guidance and dividends.
RELX share price steadies as AI fears linger, buybacks roll and Feb 12 results loom

RELX share price steadies as AI fears linger, buybacks roll and Feb 12 results loom

RELX shares traded near 2,249p in early London trading Friday after a volatile week triggered by Anthropic’s launch of new AI legal tools. The stock fell 14% Tuesday but rebounded nearly 3% Thursday. RELX continued its buyback, purchasing over 479,000 shares on Feb. 5. Investors await the company’s full-year results due Feb. 12.
GSK share price dips at London open after 52-week high — what investors watch next

GSK share price dips at London open after 52-week high — what investors watch next

GSK shares fell 0.8% to 2,162 pence in early London trading Friday, retreating from multi-decade highs after a post-earnings rally. The company forecast 2026 turnover growth of 3% to 5%, with currency effects expected to cut reported growth by about 3%. GSK announced a 70 pence dividend target for 2026 and completed £1.4 billion of a £2 billion buyback. President David Redfern sold 100,000 shares at £21.09 each.
British American Tobacco share price dips as buyback keeps ticking and Feb 12 results loom

British American Tobacco share price dips as buyback keeps ticking and Feb 12 results loom

British American Tobacco shares slipped 0.2% to 4,548 pence in early London trading Friday after announcing further share buybacks for cancellation. The company repurchased 121,668 shares on Feb. 5 and 136,167 shares on Feb. 4. Investors await BAT’s Feb. 12 results for signals on 2026 guidance and cash returns. Imperial Brands also fell about 0.5%.
Lloyds share price near 106p after BoE close vote stirs rate-cut bets

Lloyds share price near 106p after BoE close vote stirs rate-cut bets

Lloyds Banking Group shares hovered near 105.8 pence Friday after dropping 5.6% Thursday, following the Bank of England’s decision to keep rates at 3.75%. The bank bought back 7 million shares on Feb. 5 at an average 106.86 pence. UK bank stocks fell as the FTSE 100 slipped 0.9%. Investors now focus on the Bank of England’s March 19 meeting for signals on rate cuts.
1 31 32 33 34 35 2,711

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Go toTop